These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 22404448)
61. Bismuth-Based Quadruple Therapy for Clarithromycin-Resistant Lee MW; Kim GH Gut Liver; 2022 Nov; 16(6):807-808. PubMed ID: 36379903 [No Abstract] [Full Text] [Related]
62. Drugs for Helicobacter pylori infection. Med Lett Drugs Ther; 2017 Jul; 59(1525):113-117. PubMed ID: 28699931 [No Abstract] [Full Text] [Related]
63. Is 10-Day Vonoprazan With High-Dose Amoxicillin Dual Therapy Efficient for Eradicating Helicobacter pylori Infection in China? Du RC; Lu NH; Hu Y Am J Gastroenterol; 2024 Apr; 119(4):778. PubMed ID: 38372295 [No Abstract] [Full Text] [Related]
65. The Current Role of Vonoprazan in Helicobacter pylori Treatment. Fallone CA Gastroenterology; 2022 Sep; 163(3):572-574. PubMed ID: 35780869 [No Abstract] [Full Text] [Related]
66. Considering the Long-Conflicting Topic of Empirical or Nonconventional Kountouras J Gut Liver; 2023 Jul; 17(4):659-660. PubMed ID: 36916038 [No Abstract] [Full Text] [Related]
67. Clarithromycin resistance in Helicobacter pylori: implications for therapy. Fujioka T J Gastroenterol; 2000; 35(1):69-70. PubMed ID: 10632546 [No Abstract] [Full Text] [Related]
68. Eradication of Helicobacter pylori infection was associated with complete cure of resistant bleeding per gums. Ramadan M Helicobacter; 2018 Aug; 23(4):e12492. PubMed ID: 29869386 [No Abstract] [Full Text] [Related]
69. Letter: a promising Helicobacter pylori regimen - vonoprazan-based therapy. Hu Y; Lu NH Aliment Pharmacol Ther; 2022 Aug; 56(4):752-753. PubMed ID: 35879899 [No Abstract] [Full Text] [Related]
70. Letter: a promising Helicobacter pylori regimen-vonoprazan-based therapy. Author's reply. Ang D Aliment Pharmacol Ther; 2022 Aug; 56(4):754-755. PubMed ID: 35879904 [No Abstract] [Full Text] [Related]
71. Seeking an optimal eradication therapy for Helicobacter pylori infection. Miura S; Hokari R J Gastroenterol Hepatol; 2012 Jan; 27(1):7-9. PubMed ID: 22188025 [No Abstract] [Full Text] [Related]
72. Outcome evaluation of clarithromycin, metronidazole and lansoprazole regimens in Helicobacter pylori positive or negative children with resistant otitis media with effusion. Bakshi SS J Laryngol Otol; 2016 Mar; 130(3):318. PubMed ID: 26878377 [No Abstract] [Full Text] [Related]
73. Diagnosis of Helicobacter pylori recurrence: relapse or reinfection? Usefulness of molecular tools. Raymond J; Thiberge JM; Dauga C Scand J Gastroenterol; 2016; 51(6):672-8. PubMed ID: 26784882 [TBL] [Abstract][Full Text] [Related]